Thelansis

  Acute Lymphoblastic Leukemia (ALL) is a malignancy of B or T lymphoblasts characterized by uncontrolled proliferation of abnormal, immature lymphocytes and their progenitors, which ultimately leads to the replacement of bone marrow elements and other lymphoid organs, resulting in a characteristic disease pattern. Patients with ALL typically present with symptoms related to anemia, thrombocytopenia, and neutropenia, including fatigue, easy bruising or bleeding, and infections. Additional symptoms like fever, night sweats, and unintentional weight loss (B-symptoms) may also be present, although they may be mild. Physical examination may reveal hepatomegaly, splenomegaly, and lymphadenopathy. The exact cause of ALL remains unknown. However, exposure to environmental factors such as benzene, ionizing radiation, or previous chemotherapy or radiotherapy has been implicated as risk factors. ALL is not considered a hereditary disease, and no screening programs have been established. The Wo

 Acute Lymphoblastic Leukemia (ALL) is a malignancy of B or T lymphoblasts characterized by uncontrolled proliferation of abnormal, immature lymphocytes and their progenitors, which ultimately leads to the replacement of bone marrow elements and other lymphoid organs resulting in a characteristic disease pattern. Patients with ALL typically present with symptoms related to anemia, thrombocytopenia, and neutropenia, including fatigue, easy bruising or bleeding, and infections. Additional symptoms like fever, night sweats, and unintentional weight loss (B-symptoms) may also be present, although they may be mild. Physical examination may reveal hepatomegaly, splenomegaly, and lymphadenopathy. The exact cause of ALL remains unknown. However, exposure to environmental factors such as benzene, ionizing radiation, or previous chemotherapy or radiotherapy has been implicated as risk factors. ALL is not considered a hereditary disease, and no screening programs have been established. The World